RVV — Revive Therapeutics Share News
0.000.00%
Last trade - 00:00- CA$8.71m
- CA$8.71m
Brief: Revive Therapeutics Announces United States Patent Grant For Cannabinoid Delivery System
Brief: Revive Therapeutics Announces Collaboration And Royalty Deal With Richmond Cannabis
Brief: Revive Therapeutics Introduces Relicann A New Brand For Hemp-Based CBD Wellness And Medical Cannabis Market
Brief: Revive Therapeutics Applies To FDA For Orphan Drug Designation Of Cannabidiol For Treatment Of Liver Transplantation
Brief: Revive Therapeutics Announces Orphan Drug Designation For Cannabidiol In Treatment Of Autoimmune Hepatitis
Brief: Revive Therapeutics Announces FDA Grants Orphan Drug Designation For Cannabidiol In The Treatment Of Autoimmune Hepatitis
Brief: WeedMD And Revive Therapeutics Sign Medical Cannabis Research And Development Supply And Collaboration Agreements
Brief: Revive Therapeutics Announces Exclusive License Agreement With Wisconsin Alumni Research Foundation For Cannabinoid Delivery Technology
Brief: Revive Therapeutics And Ehave Enter Into Patient Research Data Collaboration Agreement
Brief: Revive Therapeutics Advances Research Program Of Cannabinoid-Based Therapies Targeting Liver Diseases
Brief: Revive Therapeutics Enters Collaboration Agreement With Health Canada Licensed Dealer For Medical Cannabis
Brief: Revive Therapeutics Enters Collaboration Agreement With Health Canada Licensed Dealer
Brief: Revive Therapeutics enters into research collaboration with Sanyal Biotechnology for liver diseases
Brief: Revive Therapeutics applies to FDA for orphan drug designation for treatment of autoimmune hepatitis
Brief: Revive Therapeutics applies to FDA for orphan drug designation for treatment of autoimmune hepatitis
Brief: Revive Therapeutics enters into a exclusive license agreement with South Carolina Research Foundation
Brief: Revive Therapeutics and South Carolina Research Foundation enter into exclusive license agreement
Brief: Revive Therapeutics provides corporate update
Brief: Revive Therapeutics announces term sheet with InMed Pharmaceuticals